Literature DB >> 2432664

Angiogenic factors.

J Folkman, M Klagsbrun.   

Abstract

Within the past 2 years, several angiogenic factors have been fully purified, their amino acid sequences determined, and their genes cloned. These polypeptides include acidic and basic fibroblast growth factor, angiogenin, and transforming growth factors alpha and beta. Other less well characterized angiogenesis factors have also been isolated, some of which are lipids. This article traces the discovery of the angiogenic factors and describes their possible significance in understanding growth regulation of the vascular system. When evaluated according to their putative targets, they appear to fall into two groups: those that act directly on vascular endothelial cells to stimulate locomotion or mitosis, and those that act indirectly by mobilizing host cells (for example, macrophages) to release endothelial growth factors. In addition to their presence in tumors undergoing neovascularization, the same angiogenic peptides are found in many normal tissues where neovascularization is not occurring. This suggests that physiological expression of angiogenic factors is tightly regulated. In addition to the persistent angiogenesis induced by tumors, it now appears that a variety of nonneoplastic diseases, previously thought to be unrelated, can be considered as "angiogenic diseases" because they are dominated by the pathologic growth of capillary blood vessels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432664     DOI: 10.1126/science.2432664

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  819 in total

1.  Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis.

Authors:  L Nelimarkka; H Salminen; T Kuopio; S Nikkari; T Ekfors; J Laine; L Pelliniemi; H Järveläinen
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates.

Authors:  L E Dike; C S Chen; M Mrksich; J Tien; G M Whitesides; D E Ingber
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

Review 4.  Angiogenesis in the corpus luteum.

Authors:  L P Reynolds; A T Grazul-Bilska; D A Redmer
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

Review 5.  A cure for cancer? Dealing with minimal residual disease.

Authors:  G C O'Sullivan
Journal:  Ir J Med Sci       Date:  2000 Jan-Mar       Impact factor: 1.568

6.  Study on angiogenesis factor of human osteosarcoma.

Authors:  H Wu; T Wang; Z Deng; D Chen
Journal:  J Tongji Med Univ       Date:  2000

7.  AngioDB: database of angiogenesis and angiogenesis-related molecules.

Authors:  Tae-Kwon Sohn; Eun-Joung Moon; Seok-Ki Lee; Hwan-Gue Cho; Kyu-Won Kim
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

Review 8.  Angiogenesis and melanoma.

Authors:  J P Dutcher
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 9.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

10.  Papillary endothelial hyperplasia in a TEC coronary atherectomy specimen.

Authors:  J G Crilley; C Ritchie; M A de Belder
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.